About AREXVY | AREXVY (Respiratory Syncytial Virus Vaccine, …
WEBAREXVY is an FDA-approved vaccine for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in people 60 years of age and older.
RSV Vaccine | AREXVY (Respiratory Syncytial Virus Vaccine, …
WEBThe First FDA-Approved RSV Vaccine for People 60 Years and Older. AREXVY protects against lung and lower airway infection caused by respiratory syncytial virus (RSV).
About RSV | AREXVY (Respiratory Syncytial Virus Vaccine, …
WEBAREXVY is an FDA-approved vaccine for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in people 60 years of age and older.
Cost & Coverage | AREXVY (Respiratory Syncytial Virus Vaccine, …
WEBAREXVY is covered for nearly all eligible patients 60 years and older with commercial insurance at no cost when administered in-network *†§. If you need cost information, visit GSKforyou.com or call 1-866-GSK-FOR-U.
Side Effects | AREXVY (Respiratory Syncytial Virus Vaccine, …
WEBReview the possible side effects of AREXVY and other important safety information. AREXVY is indicated for the prevention of RSV in adults aged 60 and older.
FAQs | AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted)
WEBExplore the answers to frequently asked questions about AREXVY and RSV. You'll also find questions to ask your doctor or pharmacist before receiving AREXVY.
Vacuna contra el VRS|AREXVY (Respiratory Syncytial Virus Vaccine ...
WEBLa primera vacuna contra el VRS aprobada por la FDA para personas de 60 años o más. AREXVY protege contra las infecciones en pulmones y vías respiratorias bajas ocasionadas por el virus respiratorio sincitial (VRS).
Sobre AREXVY | AREXVY (Respiratory Syncytial Virus Vaccine, …
WEBAREXVY es la primera vacuna aprobada por la FDA para prevenir infecciones en pulmones y vías respiratorias bajas ocasionadas por el virus respiratorio sincitial (VRS) en personas de 60 años o más.
Sobre el VRS | AREXVY (Respiratory Syncytial Virus Vaccine, …
WEBAREXVY es una vacuna aprobada por la FDA para la prevención de la enfermedad del tracto respiratorio inferior (ETRI) ocasionada por el virus respiratorio sincitial en personas de 60 años o más.
Efectos Secundarios | AREXVY (Respiratory Syncytial Virus Vaccine ...
WEBRevisa los posibles efectos secundarios de AREXVY y otra información importante de seguridad. AREXVY está indicada para la prevención del VRS en adultos de 60 años o más.